ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST

$4.82

+$0.06 (+1.36%)

Price as of Oct 9, 2026 16:23 UTC

600 M

Market Cap (Small Cap)

15%

IV Rank

79.6%

Implied Volatility

Nov 03

Next Earnings

Technical Signals as of Oct 7
Mixed
3 of 7

Trend

  • Above 20-day average $4.70
  • Above 50-day average $4.63
  • Above 200-day average $4.71 · -1.9%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 34d ago

Volume

  • Below-average volume 0.6x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

5.16

Bearish skew

Implied Volatility

79.6%

0% percentile

IV vs Realized

Options rich

30d HV 51.8%

Options Heat Map

Delta-risk grid for AQST options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 23 sells
Date Insider Title Type Shares Value Since Trade
Sep 15, 2026 Barber Daniel Sell 25,000 $120,488 -1.2%
Sep 09, 2026 Korczynski Sherry Exercise 8,750 $0 -7.6%
Sep 09, 2026 Korczynski Sherry Exercise 8,750 $23,188 +79.6%
Sep 09, 2026 Boyd Peter E. Exercise 2,293 $0 -7.6%
Sep 09, 2026 Korczynski Sherry Sell 8,750 $45,675 -8.8%
Sep 09, 2026 Boyd Peter E. Exercise 2,293 $2,201 +395.8%
Sep 08, 2026 Barber Daniel Exercise 91,743 $0 -8.6%
Sep 08, 2026 Barber Daniel Exercise 91,743 $88,073 +395.8%
Sep 03, 2026 Jung Cassie Exercise 4,587 $4,404 +395.8%
Sep 03, 2026 Jung Cassie Exercise 4,587 $0 -11.0%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 11, 2026 Q2 2026 -$0.11
Jun 30, 2026 Q2 2026 -$0.11 -$0.18 -70.8% Miss
Mar 31, 2026 Q1 2026 -$0.14 -$0.07 +50.0% Beat
Dec 31, 2025 Q4 2025 -$0.14 -$0.15 -10.9% Miss
Sep 30, 2025 Q3 2025 -$0.14 -$0.14 -3.6% Miss

Track AQST with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for AQST and your entire portfolio.